Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $29.9 million.

  • Angiodynamics' Accumulated Expenses fell 2521.61% to $29.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $29.9 million, marking a year-over-year decrease of 2521.61%. This contributed to the annual value of $35.5 million for FY2025, which is 1357.73% down from last year.
  • Per Angiodynamics' latest filing, its Accumulated Expenses stood at $29.9 million for Q4 2025, which was down 2521.61% from $27.7 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Accumulated Expenses ranged from a high of $41.1 million in Q2 2024 and a low of $21.8 million during Q1 2023
  • Over the past 5 years, Angiodynamics' median Accumulated Expenses value was $29.5 million (recorded in 2023), while the average stood at $30.6 million.
  • As far as peak fluctuations go, Angiodynamics' Accumulated Expenses surged by 5440.51% in 2024, and later crashed by 2521.61% in 2025.
  • Angiodynamics' Accumulated Expenses (Quarter) stood at $27.7 million in 2021, then fell by 4.26% to $26.5 million in 2022, then increased by 10.19% to $29.2 million in 2023, then surged by 36.54% to $39.9 million in 2024, then fell by 25.22% to $29.9 million in 2025.
  • Its last three reported values are $29.9 million in Q4 2025, $27.7 million for Q3 2025, and $35.5 million during Q2 2025.